Richard Ian Griffiths - 05 Mar 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
10%+ Owner
Signature
/s/ Richard Ian Griffiths
Issuer symbol
SLN
Transactions as of
05 Mar 2025
Net transactions value
$0
Form type
4
Filing time
06 Mar 2025, 11:03:13 UTC
Previous filing
25 Feb 2025
Next filing
31 Mar 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN American Depositary Shares Purchase +22,632 +0.24% 9,561,299 05 Mar 2025 Ordinary Shares 67,896 $4.50 By Cream Capital Limited F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") is immediately convertible into three ordinary shares for no consideration and has no expiration date.
F2 The securities are held by Cream Capital Limited ("Cream"). Mr Griffiths is a director and the controlling shareholder of Cream. Mr Griffiths disclaims beneficial ownership of these securities except to the extent of his proportionate pecuniary interest therein.